The FDA granted full approval to the menin inhibitor revumenib (Revuforj) for adults and children 1 year and older with relapsed/refractory acute leukemia and a lysine methyltransferase 2A gene ( ...

During a Case-Based Roundtable® event, Patrick M. Forde, MD, discussed safety and tolerability concerns with immunotherapy in ...

Kennedy is Trump’s pick for health secretary, but he has a history of spreading misinformation about a range of issues.

Routine blood draws during a doctor’s visit can reveal disorders or diseases and as the number of patient caseloads inches ...

The miniature models have the potential to significantly speed up vaccine development, advance cancer treatment research, and enhance health outcomes for a wide range of diseases. To gain deeper ...